Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 12.
Published in final edited form as: Angew Chem Int Ed Engl. 2014 Nov 21;54(3):860–863. doi: 10.1002/anie.201409540

Mechanistic Studies of the Radical SAM Enzyme DesII with TDP-d-Fucose**

Yeonjin Ko a, Mark W Ruszczycky a, Sei-Hyun Choi a,, Hung-wen Liu a,
PMCID: PMC4293265  NIHMSID: NIHMS647557  PMID: 25418063

Abstract

DesII is a radical SAM enzyme that catalyzes the C4-deamination of TDP-4-amino-4,6-dideoxyglucose via a C3 radical intermediate. However, if the C4 amino group is replaced with a hydroxyl (TDP-quinovose), the hydroxyl at C3 is oxidized to a ketone with no C4-dehydration. It is hypothesized that hyperconjugation between the C4 C–N/O bond and the partially filled p-orbital at C3 of the radical intermediate modulates the degree to which elimination competes with dehydrogenation. To investigate this hypothesis, the reaction of DesII with the C4-epimer of TDP-quinovose (TDP-fucose) was examined. The majority of the reaction results in the formation of TDP-6-deoxygulose and likely regeneration of TDP-fucose. The remainder of the substrate radical partitions roughly equally between C3-dehydrogenation and C4-dehydration. Thus, changing the stereochemistry at C4 permits a more balanced competition between elimination and dehydrogenation.

Keywords: Enzyme catalysis, Radical SAM, Alcohols, Biosynthesis


The radical S-adenosylmethionine (SAM) enzyme DesII from Streptomyces venezuelae catalyzes the redox-neutral deamination of TDP-4-amino-4,6-dideoxy-d-glucose (1) to generate TDP-4,6-dideoxy-3-keto-d-glucose (2, see Scheme 1).1,2 In its biological context, the deamination of 1 is the key reaction in the biosynthesis of TDP-desosamine (3), which is an essential component of many macrolide antibiotics.24 This deamination reaction is radical-mediated and is initiated via hydrogen atom abstraction from the substrate by a 5′-deoxyadenosyl radical. The latter is derived from reductive homolysis of SAM by an active site [4Fe-4S]1+ cluster and represents the hallmark of radical SAM enzymology.5

Scheme 1.

Scheme 1

Reactions catalyzed by DesII.

Two general mechanisms have been proposed for the DesII-catalyzed deamination as shown in Figure 1.1,4 In both cases, the p-orbital harboring the unpaired electron at C3 of the radical intermediate 6 must overlap productively with the C–N σ-system at C4 in order to facilitate either 1,2-migration (6→7→9/10→2) or direct elimination (6→8→9→2) of the adjacent amino group. In this regard, DesII is highly reminiscent of ethanolamine ammonia lyase (EAL), which catalyzes the deamination of ethanolamine albeit using a 5′-deoxyadenosyl radical produced from the homolysis of adenosylcobalamin rather than SAM.6 Although the chemistry of DesII is also very similar to the dehydration of 1,2-diols by the B12-dependent dioldehydratases,7 no elimination of the C2 hydroxyl from 1 is observed during the catalytic cycle of DesII.

Figure 1.

Figure 1

Possible reaction pathways for the substrate radical intermediate 6 during the DesII catalytic cycle. When R = NH3+, 6 may undergo either an elimination (e.g., 6→8→9) or 1,2-migration (6→7→9/10) to produce 2. When R = OH, 6 undergoes an oxidation likely via the ketyl radical intermediate 8 to produce 5.

DesII can also accept TDP-d-quinovose (4) as a substrate where the C4 amino group of 1 is replaced with a hydroxyl group. However, DesII does not catalyze elimination of the C4 hydroxyl from 4 to produce 2, but rather oxidation of the C3 hydroxyl group to yield 5 (see Scheme 1).1 This second, dehydrogenase activity of DesII is analogous to the oxidation of 3-deoxy-scyllo-inosamine by the radical SAM enzyme BtrN from the butirosin biosynthetic pathway8 and the dehydrogenation of a cysteine or serine residue to formylglycine catalyzed by anaerobic sulfatase maturating enzymes.9 The dual capability of DesII to operate as a lyase in one instance and a dehydrogenase in another offers an ideal model system for investigating the subtleties of radical control within an enzyme active site.

Previous EPR investigation of the dehydrogenation reaction (4→5) catalyzed by DesII identified a C3 α-hydroxyalkyl radical intermediate in which the C–O bonds at both C2 and C4 are essentially orthogonal to the p-orbital at C3.10 While the structure of the radical intermediate during deaminination has yet to be described, these observations led to the hypothesis that a difference in the binding configuration of the substrate radical is important for determining the partitioning of the C3-centered radical intermediate between the elimination and oxidation pathways (i.e., 6→2 versus 6→5). It is proposed that whenever the configuration at C4 provides sufficient hyperconjugation between the C4 C–N/O σ-system and the C3 p-orbital, then elimination proceeds more rapidly than electron transfer to the [4Fe-4S]2+ cluster, and lyase activity is observed. In contrast, if the configuration does not provide good overlap, then elimination is impeded. In this case, the more strongly reducing ketyl radical (8b) leads to faster reduction of the cluster compared to elimination of the C4 moiety, and dehydrogenase activity is observed (see references 2 and 11 for further illustration of this hypothesis). Such a mechanism would help to explain why the C2 (in 1 and 4) and C4 (in 4) hydroxyls are inert to dehydration during DesII catalysis, while α,β-dihydroxyalkyl radicals generated in solution via pulse radiolysis undergo rapid dehydration.12 This working model implies that configurational inversion at C4 of the TDP-d-quinovose substrate radical (6, R = OH) could result in C4 dehydratase activity if such a stereochemical change permits better hyperconjugation. This proposal can be tested by employing the C4 epimer of 4 (i.e., TDP-d-fucose, 12, see Scheme 3) as a potential substrate for DesII. Reported herein are results and mechanistic implications of our studies of DesII using 12 as the substrate.

Scheme 3.

Scheme 3

Summary of reactions catalyzed by DesII when TDP-d-fucose (12) serves as the substrate.

TDP-d-fucose (12) was prepared from TDP-d-glucose using 4,6-dehydratase RfbB followed by reduction with NaBH4 as previously described (see SI).1,13 The consumption of both 12 and SAM was only observed upon prolonged incubation (hour time scale) with a high concentration of 10–20 µM DesII in the presence of Na2S2O4. This corresponded to a specific activity of approximately 5×10−4 µmol·min−1mg−1 for consumption of 12 versus 1 µmol·min−1mg−1 for dehydrogenation of 4 at pH 8.0.11 The much lower specific activity of DesII towards 12 helps to explain why it was not previously recognized as a substrate.1

Three new products in addition to 5′-deoxyadenosine were observed by HPLC in the reaction of DesII with 12 as shown in Figure 2. The product peak X with a retention time of 28.4 min was isolated and characterized by electrospray ionization mass spectrometry (ESI-MS). The detection of peaks at 316.1 (positive ion, see Figure 3X) and 314.1 m/z (negative ion) suggested that species X may be a sulfinate adduct of deoxyadenosine (neutral mass: 315.1 Da). This hypothesis was supported by the observation of ESI-MS peaks at 318.1 (positive ion, see Figure 3Xd) and 316.1 m/z (negative ion) when [5′,5′-2H2]SAM was used instead of SAM. Further investigation showed that species X was also generated during prolonged coincubation of DesII, SAM and Na2S2O4 in the absence of 12; however, it was not formed if either SAM, DesII or Na2S2O4 was excluded from the reaction mixture. Based on these observations, species X was assigned as 5′-deoxyadenosyl-5′-sulfinic acid (11, see Scheme 2).

Figure 2.

Figure 2

HPLC traces showing the consumption of TDP-d-fucose (12) and SAM in the presence of DesII and Na2S2O4 at pH 8.0. Trace 1 is after 2 h without DesII. Traces 2 and 3 are after 30 min and 6 h in the presence of DesII, respectively. Retention times in Traces 2 and 3 are shifted by 2 and 4 min. Three new products (i.e., X, Y and Z) are observed as shown in the inset (from Trace 3). The formation of 5′-deoxyadenosine (5′-dAdo) is also noted. Peak A corresponds to the methylthioadenosine decomposition product of SAM.14 Peak B corresponds to thymidine monophosphate. Peak C is a contaminant in the SAM reagent.

Figure 3.

Figure 3

ESI-MS of isolated HPLC peaks X (positive ion), Y (negative ion) and Z (negative ion) from Figure 2. The spectrum in Xd corresponds to X isolated from a reaction using [5′,5′-2H2]SAM. The peak at 338.3 m/z likely corresponds to a known contaminant (i.e., erucamide) in the ESI-MS rather than the [M+Na]+ peak of X.

Scheme 2.

Scheme 2

The formation of sulfinate adducts has been reported in the reactions of two other radical SAM enzymes when Na2S2O4 is used to maintain a reduced [4Fe-4S]1+ cluster. For example, a mutant of spore photoproduct lyase has been shown to catalyze production of a sulfinic acid adduct of dithymidine monophosphate.15 The atypical radical SAM enzyme Dph2, which employs a SAM-derived 3-amino-3-carboxypropyl (ACP) radical rather than a 5′-deoxyadenosyl radical, has also been shown to produce a sulfinic acid derivative of ACP during turnover.16 However, to the best of our knowledge, the conversion of SAM to 11 in the presence of DesII and Na2S2O4 is the first report of a sulfinate derivative of 5′-deoxyadenosine being generated by a radical SAM enzyme. The specific activity for the sulfination reaction is no greater than 2×10−3 µmol•min−1mg−1 in the absence of TDP-d-fucose, and its rate of formation is reduced in the presence of the TDP-sugar. This suggests that dithionite can access the DesII active site and intercept the 5′-deoxyadenosyl radical, especially in the absence of a sugar substrate.

Both of the remaining two product peaks in Figure 2 originated from TDP-d-fucose (12). ESI-MS analysis of the major product peak (Y, retention time 30.5 min) showed signals indicative of [M–H] and [M–2H+Na] ions at 547.1 and 569.1 m/z, respectively (see Figure 3Y). This is consistent with an isomer of TDP-d-fucose; however, the HPLC retention time and relative inertness to reaction with DesII ruled out assignment as TDP-d-quinovose (4). Species Y was found to be sufficiently stable to permit collection for 1H NMR analysis, and all coupling constants between protons on the hexose ring are relatively small (< 6 Hz) indicating an absence of trans-diaxial C–H bonds. This implied a diaxial configuration of the vicinal hydroxyl groups at C3 and C4 and led to the assignment of Y as TDP-6-deoxy-d-gulose (15), which is the C3-epimer of TDP-d-fucose. However, the 1H NMR spectra of Y exhibited significant contamination due to partial decomposition, and a standard of 15 was prepared in order to confirm the assignment by both HPLC coinjection and 1H NMR spectroscopy (see SI). The formation of TDP-6-deoxy-d-gulose from TDP-d-fucose implies that net H-atom return to the C3 radical intermediate (13, see Scheme 3) of TDP-d-fucose is also possible in addition to dehydration and dehydrogenation (see below).

When the reaction was run in buffer containing at least 95% deuterium, ESI-MS analysis showed an approximately four-fold incorporation of deuterium versus protium into the product 15. In addition, 15 went from being the major distinguishable product (~80%) in H2O to a minor product in D2O (< 30%) indicating a solvent deuterium kinetic isotope effect on the partitioning of 13 between the different routes of decomposition. The deuterium content of the residual TDP-d-fucose in the D2O buffers was also investigated by mass spectrometry. Small but measurable increases in the deuteration of the residual substrate (12) were observed suggesting that net H-atom transfer is possible to both faces of the C3 radical. These results indicate that 13 is solvent accessible, and the net H-atom transferred to C3 originates from a solvent-exchangeable source (see SI).

The later eluting peak Z from the DesII reaction with TDP-d-fucose at 34.3 min coeluted with the deamination product 2. Furthermore, negative mode ESI-MS of the collected peak exhibited a signal at 529.1 m/z (see Figure 3Z). This is consistent with its assignment as the dehydration product 2. To verify the identity of peak Z as 2, the DesII reaction with 12 was further treated with the transaminase DesV, which catalyzes the reductive amination of 2 in the presence of glutamate.17,18 This resulted in the consumption of peak Z and formation of a new HPLC peak that coeluted with TDP-3-amino-3,4,6-trideoxy-d-glucose (16) as predicted (see SI). These observations indicated that DesII is indeed capable of operating as a dehydratase.

The dehydratase activity of DesII was also investigated using a DesII/DesV coupled reaction system. Under these conditions, however, TDP-3-amino-3,4,6-trideoxy-d-glucose (16) was formed in a roughly 1:1 ratio with an additional peak at a retention time also consistent with a TDP-aminosugar. Negative ion ESI-MS analysis of the new peak demonstrated a signal at 546.1 m/z suggesting the [M–H] ion of TDP-3-amino-3-deoxy-d-fucose (17). To confirm this assignment, the 3,4-ketoisomerase FdtA from Aneurinibacillus thermoaerophilus was used in combination with DesV and TDP-6-deoxy-4-keto-d-glucose to produce a standard of TDP-3-amino-3-deoxy-d-fucose (17).19,20 This standard indeed coeluted by HPLC with the second DesII/DesV product from the TDP-d-fucose reaction (see SI). The fact that the dehydrogenation product TDP-3-keto-d-fucose (14) was not directly observed during the reaction of TDP-d-fucose with DesII alone may be attributed to the poor stability of 3-keto TDP-sugars, which tend to readily decompose to TDP and ketodihydropyrans.21 The observation that both TDP-3-amino-3,4,6-trideoxy-d-glucose (16) and TDP-3-amino-3-deoxy-d-fucose (17) are generated in an approximately 1:1 ratio in the DesII/DesV reaction indicates that dehydration and dehydrogenation of TDP-d-fucose (12) compete with one another to an approximately equal extent and without racemization at C4.

In summary, despite being a poor substrate, TDP-d-fucose (12) can be recognized by DesII whereupon it undergoes H-atom abstraction at C3 (12→13 see Scheme 3). The fate of the resulting C3-centered radical intermediate 13 is of interest because of the inverted stereochemistry at C4 compared to TDP-d-quinovose (4). The majority of 13 is reduced to produce TDP-6-deoxy-d-gulose (13→15) via net H-atom transfer from a solvent-exchangeable source, and regeneration of TDP-d-fucose (13→12) likely also takes place via an analogous process. Therefore, the altered geometry at C4 of 12 compared to 1 and 4 appears to destabilize the enzyme-intermediate complex permitting access to the radical by solvent or leading to its dissociation altogether.

Of the C3-radical intermediate 13 that does not undergo reduction to 15/12, approximately 50% is oxidized to produce TDP-3-keto-d-fucose (14), which is consistent with the dehydrogenase activity of DesII towards 4. The remaining 50%, however, undergoes elimination of the C4 hydroxyl in direct analogy to the DesII catalyzed deamination of 1. This observation is mechanistically significant since the virtually exclusive partitioning of the C3 radical with substrates 1 and 4 towards either elimination or dehydrogenation, respectively, becomes roughly 1:1 upon changing the stereochemistry of the C4 center.

These results support the mechanistic hypothesis wherein the stereochemical configuration at C4 is important for determining the fate of the substrate radical intermediate and whether DesII operates as a lyase or a dehydrogenase. This model implies that the substrate radical of TDP-4-amino-4,6-dideoxy-d-glucose (6, R = NH3+) assumes a different conformation in the DesII active site compared to the radical of TDP-d-quinovose (6, R = OH). This difference in conformation would reduce the dihedral angle between the C–NH3+ σ-system and the p-orbital at C3, resulting in improved hyperconjugation and facilitating the radical induced C–N bond cleavage during deamination of 1.

Supplementary Material

Supporting Information

Acknowledgements

This work was supported by grants from the National Institutes of Health (GM035906) and Welch Foundation (F-1501).

Footnotes

**

This work was supported by grants from the National Institutes of Health (GM035906) and the Welch Foundation (F-1511).

References

  • 1.Szu P-H, Ruszczycky MW, Choi S-h, Liu H-w. J. Am. Chem. Soc. 2009;131:14030–14042. doi: 10.1021/ja903354k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.a) Ruszczycky MW, Ogasawara Y, Liu H-w. Biochim. Biophys. Acta. 2012;1824:1231–1244. doi: 10.1016/j.bbapap.2011.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Ruszczycky MW, Liu H-w. Isr. J. Chem. 2014 doi: 10.1002/ijch.201400130. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhao L, Borisova S, Yeung S-M, Liu H-w. J. Am. Chem. Soc. 2001;123:7909–7910. doi: 10.1021/ja010587x. [DOI] [PubMed] [Google Scholar]
  • 4.Szu P-h, He X, Zhao L, Liu H-w. Angew. Chem. Int. Ed. 2005;44:6742–6746. doi: 10.1002/anie.200501998. [DOI] [PubMed] [Google Scholar]
  • 5.a) Frey PA, Magnusson OT. Chem. Rev. 2003;103:2129–2148. doi: 10.1021/cr020422m. [DOI] [PubMed] [Google Scholar]; b) Frey PA, Hegeman AD, Ruzicka FJ. Rev. Biochem. Mol. Biol. 2008;43:63–88. doi: 10.1080/10409230701829169. [DOI] [PubMed] [Google Scholar]; c) Duschene KS, Veneziano SE, Silver SC, Broderick JB. Curr. Opin. Chem. Biol. 2009;13:74–83. doi: 10.1016/j.cbpa.2009.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Broderick JB, Duffus BR, Duschene KS, Shepard EM. Chem. Rev. 2014;114:4229–4317. doi: 10.1021/cr4004709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bandarian V, Reed GH. In: Chemistry and Biochemistry of B12. Banerjee R, editor. New York: John Wiley & Sons; 1999. pp. 811–833. [Google Scholar]
  • 7.Toraya T. Chem. Rev. 2003;103:2095–2127. doi: 10.1021/cr020428b. [DOI] [PubMed] [Google Scholar]
  • 8.a) Yokoyama K, Numakura M, Kudo F, Ohmori D, Egu-chi T. J. Am. Chem. Soc. 2003;129:15147–15155. doi: 10.1021/ja072481t. [DOI] [PubMed] [Google Scholar]; b) Grove TL, Ahlum JH, Sharma P, Krebs C, Booker SJ. Biochemistry. 2010;49:3783–3785. doi: 10.1021/bi9022126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.a) Szameit C, Miech C, Balleininger M, Schmidt B, von Figura K, Dierks T. J. Biol. Chem. 1999;274:15375–15381. doi: 10.1074/jbc.274.22.15375. [DOI] [PubMed] [Google Scholar]; b) Berteau O, Guillot A, Benjdia A, Rabot SJ. J. Biol. Chem. 2006;281:22464–22470. doi: 10.1074/jbc.M602504200. [DOI] [PubMed] [Google Scholar]; c) Goldman PJ, Grove TL, Sites LA, McLaughlin MI, Booker SJ, Drennan CL. Proc. Natl. Acad. Sci. U.S.A. 2013;110:8519–8524. doi: 10.1073/pnas.1302417110. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Grove TL, Ahlum JH, Qin RM, Lanz ND, Radle MI, Krebs C, Booker SJ. Biochemistry. 2013;52:2874–2887. doi: 10.1021/bi400136u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ruszczycky MW, Choi S-h, Mansoorabadi SO, Liu H-w. J. Am. Chem. Soc. 2011;133:7292–7295. doi: 10.1021/ja201212f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ruszczycky MW, Choi S-h, Liu H-w. Proc. Natl. Acad. Sci. U.S.A. 2013;110:2088–2093. doi: 10.1073/pnas.1209446110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.a) Steenken S, Davies MJ, Gilbert BC. J. Chem. Soc., Perkin Trans. 1986;2:1003–1010. [Google Scholar]; b) Steenken S. J. Phys. Chem. 1979;83:595–599. [Google Scholar]; c) Bansal KM, Gratzel M, Henglein A, Janata E. J. Phys. Chem. 1973;77:16–19. [Google Scholar]
  • 13.Takahashi H, Liu Y-n, Liu H-w. J. Am. Chem. Soc. 2006;128:1432–1433. doi: 10.1021/ja0562144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Iwig DF, Booker SJ. Biochemistry. 2004;43:13496–13509. doi: 10.1021/bi048693+. [DOI] [PubMed] [Google Scholar]
  • 15.Chandor-Proust A, Berteau O, Douki T, Gasparutto D, Ollagnier-de-Choudens S, Fontecave M, Atta M. J. Biol. Chem. 2008;283:36361–36368. doi: 10.1074/jbc.M806503200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhang Y, Zhu X, Torelli AT, Lee M, Dzikovski B, Koralewski RM, Wang E, Freed J, Krebs C, Ealick SE, Lin H. Nature. 2010;465:891–898. doi: 10.1038/nature09138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Xue Y, Zhao L, Liu H-w, Sherman DH. Proc. Natl. Acad. Sci. U.S.A. 1998;95:12111–12116. doi: 10.1073/pnas.95.21.12111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhao L. Ph.D. Thesis. Twin Cities, Minnesota: University of Minnesota; 2000. Biosynthetic studies of d-desosamine and engineered biosynthesis of methymycin/pikromycin analogs carrying modified deoxysugars. [Google Scholar]
  • 19.Melancon CE, III, Liu H-w. J. Am. Chem. Soc. 2007;129:4896–4897. doi: 10.1021/ja068254t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pfoestl A, Hofinger A, Kosma P, Messner P. J. Biol. Chem. 2003;278:26410–26417. doi: 10.1074/jbc.M300858200. [DOI] [PubMed] [Google Scholar]
  • 21.Melancon CE, III, Hong L, White JA, Liu Y-n, Liu H-w. Biochemistry. 2007;46:577–590. doi: 10.1021/bi061907y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES